The Procter & Gamble Company cash flow to debt ratio of 55.83% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

The Procter & Gamble Company's free cash flow has increased 7.85% from $14.04B last year to $15.15B, signaling increasing performance

The Procter & Gamble Company's debt to equity ratio is 0.71, which means that the company's assets are unhealthy financed, signaling financial risk.

The Procter & Gamble Company's debt has increased relative to shareholder equity from 0.68 last year to 0.71 today, signaling weakened financials

The Procter & Gamble Company has a net debt to EBITDA ratio of 1.03x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

The Procter & Gamble Company's interest coverage ratio of 21.96 indicates that earnings with good margin can cover interest payments on company debt

The Procter & Gamble Company's profit margin was 18.95% last year and is 18.23% this year, signaling decreasing performance

The Procter & Gamble Company's short-term liabilities of $38.69B exceed its short-term assets of $26.21B, signaling financial risk

The Procter & Gamble Company's return on assets of 12.04% is higher than the 5.00% threshold, indicating efficient asset utilization

The Procter & Gamble Company's return on equity of 29.55%, is higher than 15.00%, indicating good performance

The Procter & Gamble Company's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

The Procter & Gamble Company had positive net income in 5 out of 5 years, indicating stable and consistent earnings

The Procter & Gamble Company has positive free cash flow, indicating the company generates cash after capital expenditures

The Procter & Gamble Company has a free cash flow yield of 3.95%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

The Procter & Gamble Company's yearly earnings has increased 0.45% since last year from $15.97B to $16.05B, signaling increasing performance

The Procter & Gamble Company's yearly revenue has increased 3.26% since last year from $84.28B to $87.03B, signaling increasing performance

ROIC 14.92% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

The Procter & Gamble Company's 3-year revenue CAGR of 2.00% is positive, indicating growing revenue over the past 3 years

The Procter & Gamble Company had revenue growth in 5 out of 5 years, indicating consistent revenue performance

The Procter & Gamble Company had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

The Procter & Gamble Company is overvalued relative to its fair value price of 75.55 based on Base Cash Flow Valuation (DCF) model

The Procter & Gamble Company has an earnings yield of 4.03%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

The Procter & Gamble Company is overvalued relative to its fair value price of 60.20 based on Base EBITDA Valuation model

The Procter & Gamble Company has an EV/EBITDA ratio of 16.73x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

The Procter & Gamble Company is overvalued relative to its fair value price of 88.89 based on Base Earnings Fair Value model

The Procter & Gamble Company has a PEG-ratio over 1 which is considered overvalued

The Procter & Gamble Company has a price-to-book ratio of 7.20x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

The Procter & Gamble Company has a price-to-sales ratio of 4.53x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue